Saturday, July 25, 2020 2:48:50 PM
One research site was initiated at the end of May, 2020, and two sites were initiated in early June for the investigator-led COVID-19 phase 2 trial in South Korea. Dr. Dong Sik Jung, professor, in the division of infectious disease of Dong-A University Hospital, has now begun the process of screening patients.
https://www.stockwatch.com/News/Item?bid=Z-C%3AAGN-2925712&symbol=AGN®ion=C
Research institutions
I'm disappointed with SK's results thru Novotech too. Expected completed research as planned. SKoreans are usually very prompt and take responsibilities for plans and promises. I feel we may still see results even at these late dates.
Novotech and GVI apparently have the contacts for patients in many of the hot spots for COVID. I feel the initial IPF trial should fill fast too and cant see any reason for delays awaiting countries or states where enrollments may be slow.
With the building science from sources to back Dr William's research there should be plenty of impetus to be moving ASAP...
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM